Elanco Animal Health Inc (ELAN) Stock Price, Quote & News

Company Profile

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 877 352 6261

Website: www.elanco.com

Address:

450 Elanco Circle, Indianapolis, United States

Jblack500 Aug. 18 at 5:15 PM

$VRTX $ELAN $MRK $GILD $HALO ARWR BMY current basket...vrtx recent new position...added to ELAN today. Sell-off after er created opportunity. Multiple insiders made open market buys on 8/7 near this level.

0 · Reply

STACKD0E Aug. 17 at 5:57 PM

$ELAN $OSRH $ULBI $CGC 🙃✨

0 · Reply

JimmyOcarri Aug. 13 at 10:38 PM

$ELAN nice s

0 · Reply

topstockalerts Aug. 13 at 8:09 PM

Fitch Ratings upgraded Elanco Animal Health’s Long-Term Issuer Default Rating to ‘BB+’ from ‘BB’, while raising its senior secured debt rating to ‘BBB-’ from ‘BB+’ and senior unsecured debt to ‘BB+’ from ‘BB’. The outlook remains stable. The upgrade reflects Elanco’s improved competitive position, market-share gains in pet health, broad product portfolio, consistent cash generation and conservative financial policy. Since 2024, the company has reduced debt by approximately $650M through June 30, 2026, while EBITDA has increased more than 10%. Fitch expects leverage to remain below 3.5x and decline toward 3.0x by the end of 2027. Fitch forecasts free cash flow to improve from $345M in 2026 to about $575M in 2028, driven by innovation-led margin expansion, cost savings, productivity gains and working-capital management. EBITDA margins are expected to reach 21% in 2026 and remain around 21%-22% thereafter. $ELAN

0 · Reply

TaoistTrader Aug. 12 at 10:01 PM

$ELAN might be time to add some more

0 · Reply

Estimize Aug. 12 at 10:01 AM

Wall St is expecting 0.20 EPS for $ELAN Q3 [Reporting 11/10 BMO] http://www.estimize.com/intro/elan?chart=historical&metric_name=eps&utm_co

0 · Reply

Jblack500 Aug. 11 at 5:41 PM

$HALO $ELAN $ARWR $VRTX $GILD MRK BMY ANIP... Current basket...started position in VRTX, heading to 600 and will add more on dips. Reduced BMY

1 · Reply

FilingTracker Aug. 10 at 8:14 PM

$ELAN Insider purchase: https://filingtracker.ai/sec-filing/elan/form-4/2026-08-10/1739104/0001374175-26-000005

0 · Reply

garygb Aug. 8 at 1:51 PM

$ELAN Saturdays are my day to examine my losing holdings. Elanco has shown no elan. (French pun lol). Doubling down.

0 · Reply

STACKD0E Aug. 7 at 8:05 PM

$ELAN $OSRH $ULBI $CGC 👁

0 · Reply

Elanco's CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species

Aug 6, 2026, 5:31 PM EDT - 12 days ago

Elanco CEO on Boosted Forecast, Surge in Tick Bites

Aug 5, 2026, 8:00 AM EDT - 13 days ago

Elanco Animal Health Earnings Call Transcript: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 13 days ago

Elanco Animal Health Earnings release: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 13 days ago

Elanco Animal Health Slides: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 13 days ago

Elanco Animal Health Quarterly report: Q2 2026

Aug 5, 2026, 6:27 AM EDT - 14 days ago

Elanco Animal Health Reports Second Quarter 2026 Results

Jul 31, 2026, 7:32 AM EDT - 19 days ago

Elanco Releases 2025 Impact Report, Demonstrating How Animal Health Helps Meet Society's Growing Needs

Jul 22, 2026, 6:27 AM EDT - 4 weeks ago

Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Kills Ticks¹ Faster² than Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) and NexGard® Plus (afoxolaner, moxidectin, and pyrantel chewable tablets)

Jul 8, 2026, 8:00 AM EDT - 5 weeks ago

Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement

Jun 18, 2026, 7:26 AM EDT - 2 months ago

Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health

Jun 15, 2026, 8:47 AM EDT - 2 months ago

Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs

Jun 4, 2026, 7:23 PM EDT - 2 months ago

Elanco CEO on rolling out New World screwworm vaccine: 'We're prepared'

Jun 4, 2026, 12:57 PM EDT - 2 months ago

Confirmed screwworm case in Texas sends two biotech stocks higher

ZTS

Jun 4, 2026, 6:26 AM EDT - 2 months ago

Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm

Jun 3, 2026, 7:26 AM EDT - 2 months ago

New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry Resilience

Jun 2, 2026, 4:20 PM EDT - 2 months ago

Elanco Animal Health Transcript: 46th Annual William Blair Growth Stock Conference

Jun 2, 2026, 4:20 PM EDT - 2 months ago

Elanco Animal Health Slides: 46th Annual William Blair Growth Stock Conference

May 27, 2026, 8:00 AM EDT - 2 months ago

Elanco Animal Health Transcript: Stifel Jaws & Paws Conference 2026

May 21, 2026, 8:00 AM EDT - 3 months ago

Elanco Animal Health Transcript: AGM 2026

May 18, 2026, 7:27 AM EDT - 3 months ago

Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market

May 14, 2026, 8:00 AM EDT - 3 months ago

Elanco to Participate in Upcoming Investor Conferences

May 6, 2026, 4:16 PM EDT - 3 months ago

'WE WILL BE PREPARED': Inside efforts to stop screwworm outbreak

May 6, 2026, 8:00 AM EDT - 3 months ago

Elanco Animal Health Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Elanco Animal Health Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Elanco Animal Health Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Elanco Animal Health Quarterly report: Q1 2026

May 6, 2026, 6:27 AM EDT - 3 months ago

Elanco Animal Health Reports First Quarter 2026 Results

May 5, 2026, 7:00 AM EDT - 3 months ago

Elanco Animal Health Slides: Investor presentation

Apr 27, 2026, 6:23 PM EDT - 4 months ago

Elanco's Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock

Apr 16, 2026, 8:00 AM EDT - 4 months ago

Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results Announcement

Apr 9, 2026, 8:27 AM EDT - 4 months ago

Elanco Launches Advantage™ Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes*

Apr 8, 2026, 8:00 AM EDT - 4 months ago

Elanco Animal Health Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 4 months ago

Elanco Animal Health Proxy statement: Proxy filing

Mar 17, 2026, 9:00 AM EDT - 5 months ago

Elanco Animal Health Transcript: 2026 KeyBanc Capital Markets Healthcare Forum

Mar 11, 2026, 10:40 AM EDT - 5 months ago

Elanco Animal Health Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 11:30 AM EDT - 5 months ago

Elanco Animal Health Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 2, 2026, 2:30 PM EST - 6 months ago

Elanco Animal Health Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 6:00 AM EST - 6 months ago

Elanco Animal Health Slides: Investor presentation

Feb 26, 2026, 11:35 AM EST - 6 months ago

Elanco Animal Health Transcript: BofA Securities Animal Health Summit

Feb 24, 2026, 8:00 AM EST - 6 months ago

Elanco Animal Health Earnings Call Transcript: Q4 2025

Feb 24, 2026, 8:00 AM EST - 6 months ago

Elanco Animal Health Annual report: Q4 2025

Feb 24, 2026, 8:00 AM EST - 6 months ago

Elanco Animal Health Earnings release: Q4 2025

Feb 24, 2026, 8:00 AM EST - 6 months ago

Elanco Animal Health Slides: Q4 2025

Feb 24, 2026, 6:30 AM EST - 6 months ago

Elanco Animal Health Slides: Investor presentation

Feb 24, 2026, 6:27 AM EST - 6 months ago

Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results

Feb 13, 2026, 9:24 AM EST - 6 months ago

Elanco Announces Updates to Board of Directors

Jan 22, 2026, 8:00 AM EST - 7 months ago

Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement

Jan 13, 2026, 6:45 PM EST - 7 months ago

Elanco Animal Health Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 6:45 PM EST - 7 months ago

Elanco Animal Health Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 6, 2026, 8:00 AM EST - 8 months ago

Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 31, 2025, 2:00 PM EST - 8 months ago

Elanco Receives USDA Approval for Befrena™ (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis

Dec 18, 2025, 8:43 AM EST - 8 months ago

Elanco's Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs

Dec 9, 2025, 9:00 AM EST - 9 months ago

Elanco Animal Health Transcript: Investor Day 2025

Dec 9, 2025, 9:00 AM EST - 9 months ago

Elanco Animal Health Slides: FY 2025

Dec 9, 2025, 7:40 AM EST - 9 months ago

Elanco Investor Day Defines New Era as Sustainable Growth Company

Dec 4, 2025, 8:30 AM EST - 9 months ago

Elanco Animal Health Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 3, 2025, 12:30 PM EST - 9 months ago

Elanco Animal Health Transcript: Evercore ISI 8th Annual HealthCONx Conference

Nov 26, 2025, 6:15 PM EST - 9 months ago

Elanco executive appointed as Neurizon's Board Observer

Nov 21, 2025, 2:18 PM EST - 9 months ago

Elanco's drug gets emergency nod to treat deadly flesh-eating parasite in cats

Nov 21, 2025, 1:35 PM EST - 9 months ago

Elanco's Credelio™ CAT (lotilaner) Receives First FDA Emergency Use Authorization (EUA) for Treatment of New World Screwworm (NWS) in Cats

Nov 20, 2025, 8:00 AM EST - 9 months ago

Elanco to Participate in the Upcoming Investor Conferences

Nov 13, 2025, 8:00 AM EST - 9 months ago

Alloy Partners Launches OneHealth Studio to Create Startups at the Convergence of Animal, Plant and Human Health

Nov 5, 2025, 2:43 PM EST - 10 months ago

Elanco Animal Health CEO: Seeing a willingness to spend, durability even in 'consumer tested' time

Nov 5, 2025, 8:00 AM EST - 10 months ago

Elanco Animal Health Earnings Call Transcript: Q3 2025

Nov 5, 2025, 8:00 AM EST - 10 months ago

Elanco Animal Health Quarterly report: Q3 2025

Nov 5, 2025, 8:00 AM EST - 10 months ago

Elanco Animal Health Earnings release: Q3 2025

Nov 5, 2025, 8:00 AM EST - 10 months ago

Elanco Animal Health Slides: Q3 2025

Nov 5, 2025, 6:27 AM EST - 10 months ago

Elanco Animal Health Reports Third Quarter 2025 Results

Oct 27, 2025, 6:27 AM EDT - 10 months ago

Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species

Oct 24, 2025, 6:10 PM EDT - 10 months ago

Elanco gets US FDA emergency nod for dog drug as threat of flesh-eating parasite looms

Oct 24, 2025, 5:33 PM EDT - 10 months ago

Elanco Animal Health Obtains FDA Authorization for Screwworm Treatment

Oct 24, 2025, 4:55 PM EDT - 10 months ago

Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs

Oct 16, 2025, 4:32 PM EDT - 10 months ago

Elanco to Host Investor Day on December 9

Oct 1, 2025, 8:00 AM EDT - 11 months ago

Elanco Confirms Date and Conference Call for Third Quarter 2025 Financial Results Announcement

Sep 23, 2025, 6:27 AM EDT - 11 months ago

Elanco Announces FDA Approves Improved Zenrelia™ (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language

Sep 9, 2025, 8:30 AM EDT - 1 year ago

Elanco Animal Health Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 8, 2025, 6:27 AM EDT - 1 year ago

Elanco Innovation Builds Momentum, Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Reaches Blockbuster Status

Aug 27, 2025, 8:00 AM EDT - 1 year ago

Splenda® Joins Elanco and HATCH to Support 'Nutrition Secure Indianapolis' to Strengthen Family Health Through Nutrition and Education

Aug 26, 2025, 6:15 PM EDT - 1 year ago

Elanco Animal Health Set to Join S&P MidCap 400; Sarepta Therapeutics to Join S&P SmallCap 600

BBT BRKL

Aug 26, 2025, 8:00 AM EDT - 1 year ago

Elanco to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Elanco Animal Health Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Elanco Animal Health Quarterly report: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Elanco Animal Health Earnings release: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Elanco Animal Health Slides: Q2 2025

Aug 7, 2025, 6:27 AM EDT - 1 year ago

Elanco Animal Health Reports Second Quarter 2025 Results

Jul 24, 2025, 5:42 PM EDT - 1 year ago

Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs

Jul 10, 2025, 8:00 AM EDT - 1 year ago

Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement

Jul 9, 2025, 10:01 AM EDT - 1 year ago

Elanco's dog flu vaccine gets USDA nod

Jul 9, 2025, 8:27 AM EDT - 1 year ago

Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection

Jul 2, 2025, 7:09 PM EDT - 1 year ago

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001

Jblack500 Aug. 18 at 5:15 PM

0 · Reply

STACKD0E Aug. 17 at 5:57 PM

$ELAN $OSRH $ULBI $CGC 🙃✨

0 · Reply

JimmyOcarri Aug. 13 at 10:38 PM

$ELAN nice s

0 · Reply

topstockalerts Aug. 13 at 8:09 PM

0 · Reply

TaoistTrader Aug. 12 at 10:01 PM

$ELAN might be time to add some more

0 · Reply

Estimize Aug. 12 at 10:01 AM

Wall St is expecting 0.20 EPS for $ELAN Q3 [Reporting 11/10 BMO] http://www.estimize.com/intro/elan?chart=historical&metric_name=eps&utm_co

0 · Reply

Jblack500 Aug. 11 at 5:41 PM

$HALO $ELAN $ARWR $VRTX $GILD MRK BMY ANIP... Current basket...started position in VRTX, heading to 600 and will add more on dips. Reduced BMY

1 · Reply

FilingTracker Aug. 10 at 8:14 PM

$ELAN Insider purchase: https://filingtracker.ai/sec-filing/elan/form-4/2026-08-10/1739104/0001374175-26-000005

0 · Reply

garygb Aug. 8 at 1:51 PM

$ELAN Saturdays are my day to examine my losing holdings. Elanco has shown no elan. (French pun lol). Doubling down.

0 · Reply

STACKD0E Aug. 7 at 8:05 PM

$ELAN $OSRH $ULBI $CGC 👁

0 · Reply

RMAW Aug. 7 at 7:46 PM

$ELAN WHAT IN THE ACTUAL FUCK!!!!

0 · Reply

Bogeymakr Aug. 7 at 7:18 PM

$ELAN Wonder which criminal hedgies shorting this down today... down more than $ZTS which was downgraded.

0 · Reply

Bogeymakr Aug. 7 at 5:16 PM

$ELAN Very good earnings ... scratching my head on this one. nibbled.

0 · Reply

prismmarketview Aug. 7 at 2:35 PM

The FDA just granted $ELAN an Emergency Use Authorization for CLiK Extra, a wound spray that prevents New World screwworm in livestock and wildlife — from cattle and sheep to bison and Sonoran pronghorn. Yet shares slipped ~2% on the news. Here's why 👇 https://prismmarketview.com/elanco-wins-fda-emergency-authorization-for-new-world-screwworm-drug/

0 · Reply

TaoistTrader Aug. 7 at 1:34 PM

$ELAN added

0 · Reply

WAJeff Aug. 7 at 3:04 AM

$ELAN Last of this was sold at 27.25 on 8/5

1 · Reply

RMAW Aug. 6 at 5:21 PM

$ELAN THIS 10% DROP IS BULLSHIT!!

0 · Reply

MyChicago Aug. 6 at 3:18 PM

$ZOMDF $ELAN Both had good earnings. Hold Tight.

0 · Reply

EarningsInsider Aug. 5 at 1:32 PM

https://www.marketbeat.com/earnings/reports/2026-8-5-elanco-animal-health-incorporated-stock/ $ELAN Elanco Animal Health Earnings Transcri

0 · Reply

Armymike1981 Aug. 5 at 12:28 PM

$ZTS next time listen to a vet!! It would be like an IT guy telling me advice on NVDA… $ELAN is the better company!! Hands down

3 · Reply

StocktwitsEarnings Aug. 5 at 11:57 AM

$ELAN Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.11 up 450.00% YoY • Reported revenue of $1.37B up 10.23% YoY • Elanco Animal Health raised full year 2026 revenue guidance to $5.09 billion to $5.14 billion, adjusted EBITDA to $1.01 billion to $1.035 billion, and adjusted EPS to $1.10 to $1.16.

0 · Reply

DonCorleone77 Aug. 5 at 11:55 AM

$ELAN Elanco raises FY26 adjusted EPS view to $1.10-$1.16 from $1.03-$1.09 Consensus $1.07. Raises FY26 revenue view to $5.09B-$5.14B from $5.01B-$5.09B, consensus $5.05B. Raises FY26 adjusted EBITDA view to $1.01B-$1.04B from $975M-$1.01B. "Our strong second quarter performance allows us to both raise our full-year outlook and continue to invest in our innovation products, driving market share gains while expanding the total animal health industry," said Bob VanHimbergen, Executive Vice President and CFO of Elanco Animal Health. "Our faster than expected margin expansion includes good early progress on our Elanco Ascend productivity initiatives, on track to $200 million to $250 million in adjusted EBITDA net savings by 2030. With a net leverage ratio of 3.1x at quarter-end, also faster than expected, we are closing in on our target of reaching below 3x next year, a key milestone that will unlock greater capital allocation flexibility."

0 · Reply

Market Cap	11.80B
Revenue (ttm)	4.72B
Net Income (ttm)	-232.00M
EPS (ttm)	N/A
PE Ratio	22.33
Forward PE	21.09
Profit Margin	-4.92%
Debt to Equity Ratio	0.59

Volume	5,083,100
Avg Vol	6,326,350
Day's Range	N/A - N/A
Shares Out	499.62M
Stochastic %K	58%
Beta	1.67
Analysts	Strong Sell
Price Target	$31.54